The EBMT
Alberto Mussetti currently serves as a JACIE clinical inspector at The EBMT, specializing in evaluating compliance of transplant centers with clinical standards, and also chairs the Artificial Intelligence Subcommittee for the Transplant Complications Working Party. Mussetti holds the position of Director of the Hematopoietic Cell Transplantation and Cell Therapy Unit at the Catalan Institute of Oncology and has extensive experience in hematology and cell therapy, including roles as a consultant hematologist and cell therapy coordinator. In addition to editorial duties with Frontiers in Immunology, Mussetti has been involved in academic teaching and has contributed to various research initiatives and workshops related to oncology and transplantation. Education includes a Doctor of Medicine degree and residency training in Hematology from Università degli Studi di Milano.
This person is not in any teams
The EBMT
The EBMT is a non-profit medical and scientific organisation established in 1974 which hosts a unique patient registry providing a pool of data to perform studies and assess new trends. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit www.ebmt.org to learn more about membership, JACIE Accreditation, educational opportunities and how to get involved. Are you interested in working with us? Check out our open career opportunities on our website at: https://www.ebmt.org/career-opportunities Follow us on Twitter, Facebook and YouTube @TheEBMT.